Table 3.
Epidemiological characteristics of kidney injury in COVID-19 patients.
| First author, source, year | Location | No. of patients | No. of severe patients (%) | No. of patients with AKI (%) | No. of severe patients with AKI (%) |
|---|---|---|---|---|---|
| Guan W, N Engl J Med, 2020 [13] | China | 1,099 | 173 (15.7%) | 6 (0.6%) | 5 (2.9%) |
| Hu L, medRxiv, 2020 [85] | Wuhan | 323 | 152 (47.1%) | 17 (5.3%) | 15 (9.9%) |
| Huang C, Lancet, 2020 [5] | Wuhan | 41 | 13 (31.7%) | 3 (7.3%) | 3 (23.1%) |
| Wan S, J of Med Viro, 2020 [97] | Chongqing | 135 | 40 (29.6%) | 5 (3.7%) | 1 (2.5%) |
| Wang D, JAMA, 2020 [6] | Wuhan | 138 | 36 (26.1%) | 5 (3.6%) | 3 (8.3%) |
| Xu YH, medRxiv, 2020 [11] | Guangdong | 45 | 45 (100.0%) | 7 (15.6%) | 7 (15.6%) |
| Yang X, Lancet Respir Med, 2020 [9] | Wuhan | 52 | 52 (100.0%) | 15 (28.9%) | 15 (28.9%) |
| Zhang GQ, medRxiv, 2020 [10] | Wuhan | 221 | 55 (24.9%) | 10 (4.5%) | 8 (14.6%) |
| Zhao W, medRxiv, 2020 [103] | Beijing | 77 | 20 (26.0%) | 2 (2.6%) | 1 (5.0%) |
AKI: acute kidney injury.